FSA issues warning against clone firm

cloned-businessmanBritain’s Financial Services Authority (FSA) has issued a warning against A Walker Associates, an unauthorised clone firm. The firm is also known under the names Andrew Walker Associates and AW Associates. It uses the FSA registration number 414899 that belongs to Andrew Walker, an appointed representative firm of St James’s Palace Wealth Management. Its website www.awalkerassociates.com is still online. It appears to be hosted on WordPress, which offers mostly free website-building tools for bloggers. In a statement, the FSA said the firm had “no association whatsoever” with Andrew Walker and was not authorised under the Financial Services and Markets Act 2000 to carry on a regulated activity. This includes activities such as advising on investments, dealing and arranging deals in investments. The FSA warned that the Financial Ombudsman Service and the  Financial Services Compensation Scheme werenot available for investors dealing with an unauthorised company or individual.
©2012 funds europe

Executive Interviews

INTERVIEW: Put your money where your mouth is

Jun 10, 2016

At Kempen Capital Management, they believe portfolio managers should invest in their own funds. David Stevenson talks to Lars Dijkstra, CIO of the €42 billion manager.

EXECUTIVE INTERVIEW: ‘Volatility is the name of the game’

May 13, 2016

Axa Investment Managers chief executive officer, Andrea Rossi, talks to David Stevenson about bringing all his firm’s subsidiaries under one name and the opportunities that a difficult market...


ROUNDTABLE: Beyond the hype

Oct 13, 2016

The use of smart beta investing continues to grow. Our panel, made up of both providers and users, discusses what the strategy actually means, how it should be used and the kind of pitfalls that may arise when using this innovative investment technique.

MIFID II ROUNDTABLE: Following the direction of travel

Sep 07, 2016

Fund management firms Aberdeen and HSBC Global meet with specialist providers to speak about how the industry is evolving towards MiFID II.